Comparison of a new In-House HIV-1 TaqMan Real-Time PCR and three commercial HIV-1 RNA quantitative assays

ConclusionsThe newly developed method has suitable sensitivity, accuracy, and precision. In addition, it is cost-benefit and can be an alternative in all laboratories. (Source: Comparative Immunology, Microbiology and Infectious Diseases)

from #Head and Neck by Sfakianakis via simeraentaxei on Inoreader https://ift.tt/2Mv9cZG